KRISTEN PAWLOWSKI: Open Payments
NPI 1407118615 · DENVER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,570 in 97 payments from 17 companies in 2025. Trend: 2023 $1,805 · 2024 $1,790 · 2025 $1,570
Food & beverage: $1,570
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 15 | $303 |
| Novartis Pharmaceuticals Corporation | 20 | $279 |
| Amgen Inc. | 21 | $181 |
| GlaxoSmithKline, LLC. | 10 | $177 |
| ANI Pharmaceuticals, Inc. | 6 | $131 |
| Radius Health, Inc. | 4 | $97 |
| Fresenius Kabi USA, LLC | 5 | $91 |
| UCB, Inc. | 4 | $74 |
| Collegium Pharmaceutical, Inc. | 4 | $63 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $28 |
Products named: TREMFYA, COSENTYX, BENLYSTA, PURIFIED CORTROPHIN GEL, Tymlos, OTEZLA, ENBREL, Bimzelx.
Industry payments across NC — which companies pay providers there.
